Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Hess

Showing results (31-40 of 217) with videos related to

Pageof 22
Sort By:
BMC Bioinformatics|December 3, 2011
Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problemsKenneth R Hess, Caimiao Wei, Yuan Qi, et al.
Molecular Carcinogenesis|June 18, 2011
DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancerXiaoqun Dong, Yanan Li, Ping Chang, et al.
Gastroenterology|April 27, 2010
Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancerXiaoqun Dong, Milind Javle, Kenneth R Hess, et al.
Academic Radiology|July 18, 2019
Imaging Follow-up Versus Surgical Excision for Radial Scars Identified on Tomosynthesis-Guided Core Needle BiopsySarah Martaindale, Toma S Omofoye, Davis C Teichgraeber, et al.
Stereotactic and Functional Neurosurgery|January 16, 2017
Use of Spinal Cord Diffusion Tensor Imaging to Quantify Neural Ablation and Evaluate Outcome after Percutaneous Cordotomy for Intractable Cancer PainAditya Vedantam, Ping Hou, T Linda Chi, et al.
Journal of Neuro-Oncology|April 21, 2015
Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?Isaac Melguizo-Gavilanes, Janet M Bruner, Nandita Guha-Thakurta, et al.
Neuro-Oncology|October 11, 2005
Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variablesYi-Hong Zhou, Kenneth R Hess, Longjian Liu, et al.
JAMA Oncology|January 27, 2018
Comparison of Residual Risk-Based Eligibility vs Tumor Size and Nodal Status for Power Estimates in Adjuvant Trials of Breast Cancer TherapiesWei Wei, Tomoko Kurita, Kenneth R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancerLajos Pusztai, Kristine Broglio, Fabrice Andre, et al.
Neuro-Oncology|July 29, 2004
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiformeSiew-Ju See, Victor A Levin, W-K Alfred Yung, et al.
Pageof 22

Showing results (31-40 of 217) with videos related to

Sort By:
Pageof 22
BMC Bioinformatics|December 3, 2011
Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problemsKenneth R Hess, Caimiao Wei, Yuan Qi, et al.
Molecular Carcinogenesis|June 18, 2011
DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancerXiaoqun Dong, Yanan Li, Ping Chang, et al.
Gastroenterology|April 27, 2010
Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancerXiaoqun Dong, Milind Javle, Kenneth R Hess, et al.
Academic Radiology|July 18, 2019
Imaging Follow-up Versus Surgical Excision for Radial Scars Identified on Tomosynthesis-Guided Core Needle BiopsySarah Martaindale, Toma S Omofoye, Davis C Teichgraeber, et al.
Stereotactic and Functional Neurosurgery|January 16, 2017
Use of Spinal Cord Diffusion Tensor Imaging to Quantify Neural Ablation and Evaluate Outcome after Percutaneous Cordotomy for Intractable Cancer PainAditya Vedantam, Ping Hou, T Linda Chi, et al.
Journal of Neuro-Oncology|April 21, 2015
Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?Isaac Melguizo-Gavilanes, Janet M Bruner, Nandita Guha-Thakurta, et al.
Neuro-Oncology|October 11, 2005
Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variablesYi-Hong Zhou, Kenneth R Hess, Longjian Liu, et al.
JAMA Oncology|January 27, 2018
Comparison of Residual Risk-Based Eligibility vs Tumor Size and Nodal Status for Power Estimates in Adjuvant Trials of Breast Cancer TherapiesWei Wei, Tomoko Kurita, Kenneth R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancerLajos Pusztai, Kristine Broglio, Fabrice Andre, et al.
Neuro-Oncology|July 29, 2004
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiformeSiew-Ju See, Victor A Levin, W-K Alfred Yung, et al.
Pageof 22